Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Oct 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 5144450019 | Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5144451015 | Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5144452010 | Radioligand therapy using lutetium (177-Lu) labelled somatostatin analogue | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5144453017 | Lutetium (177-Lu) labeled somatostatin analog therapy | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5144454011 | Lutetium (177-Lu) labelled somatostatin analogue therapy | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
| 5144458014 | A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labeled somatostatin analog and a cell-targeting compound known as a ligand. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| 5144461010 | A targeted cancer treatment that delivers radiation to select types of cells using a radioligand. A radioligand has two components, a radioisotope, in this case, lutetium (177-Lu) labelled somatostatin analogue and a cell-targeting compound known as a ligand. | en | Definition | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | Is a | Radionuclide therapy | true | Inferred relationship | Some | ||
| Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | Method | Radioactive destruction | true | Inferred relationship | Some | 1 | |
| Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | Using substance (attribute) | Lutetium (177-Lu) labeled somatostatin analog (substance) | true | Inferred relationship | Some | 1 | |
| Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | Has intent | Therapeutic | false | Inferred relationship | Some | 2 | |
| Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | Using energy (attribute) | Radiation | false | Inferred relationship | Some | 2 | |
| Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | Is a | Radiotherapy | true | Inferred relationship | Some | ||
| Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | Using energy (attribute) | Radiation | true | Inferred relationship | Some | 3 | |
| Radioligand therapy using lutetium (177-Lu) labeled somatostatin analog (procedure) | Method | Administration - action | true | Inferred relationship | Some | 3 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR